Physician profile
Robert Mcvety
NPI 1396156600
$4,751.83
in general payments reported to CMS, 2019-2025
12 companies · $15.48 in 2025
The $15.48 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2021: $1,434 · 2022: $2,722 · 2023: $168 · 2025: $15.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $183.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Strategic Dentistry LLC | $2,697.00 | 2022 | |
| Salvin Dental Specialties, INC. | $1,422.82 | 2021 | |
| Align Technology, INC. | $198.00 | 2019 | |
| Henry Schein, INC. | $152.18 | 2019 | |
| Biohorizons Implant Systems INC. | $84.24 | 2023 | Biohorizons |
| Straumann USA LLC | $83.36 | 2023 | |
| Hu-Friedy Mfg. Co., LLC | $34.62 | 2019 | |
| 3m Company | $27.79 | 2019 | |
| Voco America INC. | $15.48 | 2025 | Admira Fusion X-Tra, Voco Retraction Paste, Voco Profluorid Varnish |
| Orapharma, A Division of Bausch Health US, LLC | $12.96 | 2022 | |
| Dentsply Sirona INC | $12.04 | 2022 | |
| Philips North America LLC | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcvety listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.